Review article · 2023 · Open access
Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward
The Annual Review of Pharmacology and Toxicology, 64(1), 33–51 · Published 28 July 2023 · DOI 10.1146/annurev-pharmtox-051921-091209
In brief
“Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward” is a 2023 review article by Volker Martin Lauschke and 2 co-authors, published in The Annual Review of Pharmacology and Toxicology. OpenAlex counts 64 citations as of 21 November 2026, which puts it in the top 5% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at The Annual Review of Pharmacology and Toxicology.
- Citations
- 64
- Most cited in
- 2026 (24)
- Field-weighted impact
- 2.02
- References
- 125
- Authors
- 3
Abstract
Interindividual variability in genes encoding drug-metabolizing enzymes, transporters, receptors, and human leukocyte antigens has a major impact on a patient's response to drugs with regard to efficacy and safety. Enabled by both technological and conceptual advances, the field of pharmacogenomics is developing rapidly. Major progress in omics profiling methods has enabled novel genotypic and phenotypic characterization of patients and biobanks. These developments are paralleled by advances in machine learning, which have allowed us to parse the immense wealth of data and establish novel genetic markers and polygenic models for drug selection and dosing. Pharmacogenomics has recently become more widespread in clinical practice to personalize treatment and to develop new drugs tailored to specific patient populations. In this review, we provide an overview of the latest developments in the field and discuss the way forward, including how to address the missing heritability, develop novel polygenic models, and further improve the clinical implementation of pharmacogenomics.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Lauschke, V. M., Zhou, Y., & Ingelman‐Sundberg, M. (2023). Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward. The Annual Review of Pharmacology and Toxicology, 64(1), 33–51. https://doi.org/10.1146/annurev-pharmtox-051921-091209
MLA 9
Lauschke, Volker Martin, et al. “Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward.” The Annual Review of Pharmacology and Toxicology, vol. 64, no. 1, 2023, pp. 33–51. https://doi.org/10.1146/annurev-pharmtox-051921-091209.
Chicago
Lauschke, Volker Martin, Yitian Zhou, and Magnus Ingelman‐Sundberg. 2023. “Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward.” The Annual Review of Pharmacology and Toxicology 64 (1): 33–51. https://doi.org/10.1146/annurev-pharmtox-051921-091209.
Harvard
Lauschke, V. M., Zhou, Y. and Ingelman‐Sundberg, M. (2023) ‘Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward’, The Annual Review of Pharmacology and Toxicology, 64(1), pp. 33–51. doi:10.1146/annurev-pharmtox-051921-091209.
IEEE
V. M. Lauschke, Y. Zhou, and M. Ingelman‐Sundberg, “Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward,” The Annual Review of Pharmacology and Toxicology, vol. 64, no. 1, pp. 33–51, 2023, doi: 10.1146/annurev-pharmtox-051921-091209.
BibTeX
@article{lauschke2023pharmacogenomics,
title = {{Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward}},
author = {Lauschke, Volker Martin and Zhou, Yitian and Ingelman‐Sundberg, Magnus},
journal = {The Annual Review of Pharmacology and Toxicology},
year = {2023},
volume = {64},
number = {1},
pages = {33--51},
doi = {10.1146/annurev-pharmtox-051921-091209},
url = {https://doi.org/10.1146/annurev-pharmtox-051921-091209}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 3 | |
| 2024 | 16 | |
| 2025 | 21 | |
| 2026 | 24 |
Its field-weighted citation impact is 2.02: it has been cited 2.02 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- pharmacogenomics
- polygenic model
- missing heritability
- drug-metabolizing enzymes
- drug transporters
- drug receptors
- human leukocyte antigen
- interindividual variability
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Lauschke, V. M., Zhou, Y., & Ingelman‐Sundberg, M. (2023). Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward. The Annual Review of Pharmacology and Toxicology, 64(1), 33–51. https://doi.org/10.1146/annurev-pharmtox-051921-091209
How many times has this paper been cited?
64 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at The Annual Review of Pharmacology and Toxicology: sign in and open the PDF from this page.
Who wrote this paper?
Volker Martin Lauschke, Yitian Zhou, Magnus Ingelman‐Sundberg.
What is the DOI of this paper?
10.1146/annurev-pharmtox-051921-091209, permanently at https://doi.org/10.1146/annurev-pharmtox-051921-091209. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.